...
首页> 外文期刊>Bioorganic and Medicinal Chemistry Letters >Development of tricyclic hydroxy-1H-pyrrolopyridine-trione containing HIV-1 integrase inhibitors.
【24h】

Development of tricyclic hydroxy-1H-pyrrolopyridine-trione containing HIV-1 integrase inhibitors.

机译:开发含有HIV-1整合酶抑制剂的三环羟基-1H-吡咯并吡啶-三酮。

获取原文
获取原文并翻译 | 示例
           

摘要

New tricyclic HIV-1 integrase (IN) inhibitors were prepared that combined structural features of bicyclic pyrimidinones with recently disclosed 4,5-dihydroxy-1H-isoindole-1,3(2H)-diones. This combination resulted in the introduction of a nitrogen into the aryl ring and the addition of a fused third ring to our previously described inhibitors. The resulting analogues showed low micromolar inhibitory potency in in vitro HIV-1 integrase assays, with good selectivity for strand transfer relative to 3'-processing.
机译:制备了新的三环HIV-1整合酶(IN)抑制剂,该抑制剂将双环嘧啶酮的结构特征与最近公开的4,5-二羟基-1H-异吲哚-1,3(2H)-二酮结合在一起。这种结合导致将氮引入芳基环并向我们先前描述的抑制剂中加入稠合的第三环。所得类似物在体外HIV-1整合酶测定中显示出低的微摩尔抑制力,相对于3'加工,对链转移具有良好的选择性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号